Global Think Tank on Steatotic Liver Disease

Recent news from Barcelona: As a function of the very first Global Think Tank on Steatotic Liver Disease, supported by the Barcelona Institute for Global Health (ISGlobal) and held in the Palau Macaya of Barcelona on June 5-6, 2025, 100+ international experts issued a...

MASLD and Type 2 Diabetes

An article recently published in Diabetes Care highlights the significant interplay between metabolic dysfunction–associated steatotic liver disease (MASLD) and type 2 diabetes. Summary– 🔄 Bidirectional Relationship Between MASLD and T2D Prevalence:...

Improving QOL For Decompensated Cirrhosis Patients

Consider the article titled “Decompensated Liver Cirrhosis Care” from Gastroenterology & Endoscopy News (May 2025), which focuses on enhancing quality of life (QOL) and symptom management for patients with decompensated liver cirrhosis....

Perfusion & Liver Transplant Outcomes

A recent study published in JAMA Surgery highlights the benefits of normothermic machine perfusion (NMP) in liver transplantation, particularly for organs from donation after circulatory death (DCD) donors. NMP involves preserving donor livers at body temperature with...

MASLD/MASH Meds Pipeline

“The liver cirrhosis treatment market is poised for significant growth, driven by the rising global prevalence of liver diseases, particularly NAFLD, fueled by lifestyle factors like obesity, alcohol consumption, and metabolic syndrome. Technological...